Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Translational Vision Science & Technology|July 12, 2019
Sleep-Wake Disturbance Related to Ocular Disease: A Systematic Review of Phase-Shifting Pharmaceutical TherapiesColm D Andrews, Russell G Foster, Iona Alexander, et al.
The British Journal of Ophthalmology|March 14, 2019
Long-term efficacy and tolerability of TNFα inhibitors in the treatment of non-infectious ocular inflammation: an 8-year prospective surveillance studySrilakshmi M Sharma, Erika Damato, Ann E Hinchcliffe, et al.
Clinical & Experimental Optometry|May 7, 2020
Low-contrast visual acuity versus low-luminance visual acuity in choroideremiaLaura J Wood, Jasleen K Jolly, Colm D Andrews, et al.
The Lancet. Public Health|June 28, 2024
Changes in opioid prescribing during the COVID-19 pandemic in England: an interrupted time-series analysis in the OpenSAFELY-TTP cohortAndrea L Schaffer, Colm D Andrews, Andrew D Brown, et al.
The Lancet. Rheumatology|January 22, 2024
Gout incidence and management during the COVID-19 pandemic in England, UK: a nationwide observational study using OpenSAFELYMark D Russell, Jon Massey, Edward Roddy, et al.
BMJ (Clinical Research Ed.)|March 15, 2023
Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPPWilliam J Hulme, Elsie M F Horne, Edward P K Parker, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 2, 2026
Recording of Pharmacy First consultations in general practice records in England: an observational study of the service's first year using OpenSAFELYViveck J Kingsley, Milan Wiedemann, Christopher Wood, et al.
Epidemiology (Cambridge, Mass.)|June 24, 2024
Effectiveness of mRNA COVID-19 Vaccines as First Booster Doses in England: An Observational Study in OpenSAFELY-TPPElsie M F Horne, William J Hulme, Edward P K Parker, et al.
Pageof 2